The Latest

  • COUR Pharmaceuticals Secures FDA Clearance of IND Application for CNP-103 in Type 1 Diabetes
  • Skip to primary navigation
  • Skip to main content
  • Skip to footer
COUR Pharmaceuticals Logo

COUR Pharmaceuticals

  • Our Company
    • Leadership
    • Board of Directors
    • Advisors
    • Partners
    • Contact
  • Our Technology
    • Pipeline
  • Our Clinical Trials
    • CNP-106 Myasthenia Gravis
  • Publications & Media
    • Press Releases
    • Publications
  • Careers

Advisors

COUR’s medical advisors bring unique medical perspectives and expertise to drive the strategic direction and success for potentially life-changing technology.

Ciarán P. Kelly, MD
Ciarán P. Kelly, MD Featured

Ciarán P. Kelly, MD

Harvard Medical School

M. Eric Gershwin, MD, MACP, MACR
M. Eric Gershwin, MD, MACP, MACR Featured

M. Eric Gershwin, MD, MACP, MACR

University of California, Davis

Stephen D. Miller, PHD
Stephen D. Miller, PHD Featured

Stephen D. Miller, PHD

Northwestern University

Lonnie D. Shea, PHD
Lonnie D. Shea, PHD Featured

Lonnie D. Shea, PHD

University of Michigan

Lee S. Simon, MD, FACP, MACR
Lee S. Simon, MD, FACP, MACR Featured

Lee S. Simon, MD, FACP, MACR

Principal, SDG LLC

Jay Skyler, MD
Jay Skyler, MD Featured

Jay Skyler, MD

University of Miami

Richard J. Nowak, MD
Richard J. Nowak, MD Featured

Richard J. Nowak, MD

Yale University

Peter Gottlieb, MD
Peter Gottlieb, MD Featured

Peter Gottlieb, MD

University of Colorado

Footer

COUR Pharmaceuticals Logo
  • Our Company
  • Our Technology
  • Our Partners
  • Press
  • Careers

©

2025

COUR Pharmaceuticals.
All Rights Reserved.

Privacy Policy • Terms of Use

Back to Top